Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil. Clinics [Internet]. 2019 May 24 [cited 2024 May 6];74:e771. Available from: https://www.revistas.usp.br/clinics/article/view/162039